Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders

Peter W. Kalivas; Sade Spencer

doi:10.1016/j.biopsych.2018.11.019

Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders

Peter W. Kalivas
, Sade Spencer

Pharmacology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e61
Journal	Biological Psychiatry
Volume	85
Issue number	11
DOIs	https://doi.org/10.1016/j.biopsych.2018.11.019
State	Published - Jun 1 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

PubMed: MeSH publication types

Letter
Research Support, N.I.H., Extramural
Comment

Publisher link

10.1016/j.biopsych.2018.11.019

https://linkinghub.elsevier.com/retrieve/pii/S000632231832050X

Find It

Find It at U of M Libraries

Cite this

@article{1d541390c8954b43acd16f3d58ea085a,

title = "Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders",

author = "Kalivas, \{Peter W.\} and Sade Spencer",

year = "2019",

month = jun,

day = "1",

doi = "10.1016/j.biopsych.2018.11.019",

language = "English (US)",

volume = "85",

pages = "e61",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Reply to

T2 - N-Acetylcysteine in Treatment of Substance Use Disorders

AU - Kalivas, Peter W.

AU - Spencer, Sade

PY - 2019/6/1

Y1 - 2019/6/1

UR - https://www.scopus.com/pages/publications/85065418714

UR - https://www.scopus.com/pages/publications/85065418714#tab=citedBy

U2 - 10.1016/j.biopsych.2018.11.019

DO - 10.1016/j.biopsych.2018.11.019

M3 - Letter

C2 - 30563761

SN - 0006-3223

VL - 85

SP - e61

JO - Biological Psychiatry

JF - Biological Psychiatry

IS - 11

ER -

Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders

UN SDGs

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this